logo

Teva Pharmaceutical Industries Limited (TEVA)



Trade TEVA now with
  Date
  Headline
8/16/2018 7:02:28 AM Regeneron, Teva Unveil Positive Topline Phase 3 Fasinumab Results In Patients With Chronic Pain From OA Of Knee/Hip
8/6/2018 8:02:24 AM Teva Says FDA Approved GRANIX Injection For New Vial Presentation And Indication In Pediatric Patients 1 Month And Older
8/2/2018 7:17:51 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 EPS Estimate To 2.55 - 2.80 From 2.40 - 2.65
8/2/2018 7:01:16 AM Teva Q2 GAAP Loss Per Share $0.24; Non-GAAP EPS $0.78
7/9/2018 10:58:21 AM Teva Launches Generic Version Of Uceris In United States
6/15/2018 8:01:41 AM Teva Provides Update On Clinical Trial Of Fremanezumab For Use In Chronic Cluster Headache
5/23/2018 8:00:58 AM Teva Confirms September 16 As PDUFA Date For Fremanezumab
5/15/2018 11:08:48 AM Teva Announces Publication Of Phase III Trial Data Of Fremanezumab For Preventive Treatment Of Episodic Migraine
5/3/2018 7:14:28 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 Revenue Estimate To $18.5 - $19.0 Bln From $18.3 - $18.8 Bln